targeted emitters hold great promise therapeutics micrometastatic disease high energy deposition short range tumor targeted result high killing minimal irradiation potential generator therapy decays halflife generates daughters retention 225ac daughters target increases efficacy escape distribution body increases toxicity circulation molecular carriers conjugated 225ac retain daughters previously proposed liposomal encapsulation 225ac retain daughters retention shown dependent daughter retention lower expected NUMBER theoretical maximum decreasing NUMBER partially binding 225ac phospholipid membrane study multivesicular liposomes muvels composed different phospholipids developed increase daughter retention muvels large liposomes entrapped smaller containing 225ac pegylated muvels stably retained time NUMBER encapsulated 225ac retention 213bi daughter NUMBER theoretical maximum retention 213bi liposome sizes studied muvels conjugated antibody immunolabeled muvels evaluated vitro ovarian cancer cells exhibiting significant cellular internalization NUMBER work demonstrates immunolabeled muvels able deliver higher fractions generated targeted 225ac compared relative fractions delivered molecular carriers alpha particle alpha particles cancer cell normal tissue actinium NUMBER alpha particle NUMBER day alpha particle emitting liposome size lipid vesicles anti skov3 nmp2 alpha particles alpha particles 225ac labeled her2 neu